OncLive Oct 18, 2023
Russell Pachynski MD discusses the ongoing investigation of ARX517 in patients with advanced solid tumors in the phase 12 APEX-01 trial.
OncLive Oct 18, 2023
Russell Pachynski MD discusses the ongoing investigation of ARX517 in patients with advanced solid tumors in the phase 12 APEX-01 trial.